Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bin Wang
Huzhou Central Hospital，Taizhou，China
Principal Investigator - Fei J Zhu
Taizhou Central Hospital，Taizhou，China
Principal Investigator - Jun Chen
Ningbo Yinzhou People's Hospital，Ningbo, China
Principal Investigator - Jun G Zhang
The First Affiliated Hospital of Zhengzhou University，Zhengzhou,China
Principal Investigator - Ping Yu Li
The First Affiliated Hospital of Wenzhou Medical University，Wenzhou，China
Principal Investigator - Qin Li Lu
Zhejiang Provincial People's Hospital，Hangzhou, China
Principal Investigator - Qiu Y Zhao
Henan Cancer Hospital，Henan，China
Principal Investigator - Rong R Zhou
Xiangya Hospital of Central South University，Changsha，China
Principal Investigator - Wu G Wu
Meizhou People's Hospital，Meizhou，China
Principal Investigator - Yan X Lin
Union Hospital Affiliated to Fujian Medical University，Fujian，China
Principal Investigator - Yan Yu
Heilongjiang Cancer Hospital，Heilongjiang，China
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Hospital Affiliated To University of Chinese Academy of Sciences
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jul 2021
- Primary completion
- 15 Jun 2024
- Completion
- 15 Jul 2024
- Last update posted
- 22 Apr 2024
- Registered enrollment
- 63
- Registry id
- NCT04808752
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.